Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo

Journal of Cell Biology

Volumn 164, Issue 4, 2004, Pages 509-514

  Dacquin, Romain ^a   Davey, Rachel A ^b   Laplace, Catherine ^c   Levasseur, Régis ^a   Morris, Howard A ^d   Goldring, Steven R ^c   Gebre Medhin, Samuel ^e   Galson, Deborah L ^c,f   Zajac, Jeffrey D ^b   Karsenty, Gérard ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HANSON INSTITUTE   (Australia)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

CALCR; CTR; Islet amyloid polypeptide; Mouse models; Osteoclast

Indexed keywords

AMYLIN; CALCITONIN; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; OSTEOCLAST DIFFERENTIATION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MASS; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HETEROZYGOTE; HISTOLOGY; MACROPHAGE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

AMYLOID; ANIMALS; BONE AND BONES; BONE DENSITY; BONE RESORPTION; CELL DIFFERENTIATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASES; OSTEOCLASTS; OSTEOGENESIS; PHENOTYPE; RECEPTORS, CALCITONIN;

ANIMALIA;

EID: 10744220002     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.200312135     Document Type: Article

References (24)

1. Anusaksathien, O., C. Laplace, X. Li, Y. Ren, L. Peng, S.R. Goldring, and D.L. Galson. 2001. Tissue-specific and ubiquitous promoters direct the expression of alternatively spliced transcripts from the calcitonin receptor gene. J. Biol. Chem. 276:22663-22674.
2. Boyle, W.J., W.S. Simonet, and D.L. Lacey. 2003. Osteoclast differentiation and activation. Nature. 423:337-342.
3. Chen, Y., J.F. Shyu, A. Santhanagopal, D. Inoue, J.P. David, S.J. Dixon, W.C. Horne, and R. Baron. 1998. The calcitonin receptor stimulates Shc tyrosine phosphorylation and Erk1/2 activation. Involvement of Gi, protein kinase C, and calcium. J. Biol. Chem. 273:19809-19816.
4. Christopoulos, G., K.J. Perry, M. Morfis, N. Tilakaratne, Y. Gao, N.J. Fraser, M.J. Main, S.M. Foord, and P.M. Sexton. 1999. Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. Mol. Pharmacol. 56:235-242.
5. Cornish, J., K.E. Callon, A.R. King, G.J. Cooper, and I.R. Reid. 1998. Systemic administration of amylin increases bone mass, linear growth, and adiposity in adult male mice. Am. J. Physiol 275:E694-E699.
6. Cornish, J., K.E. Callon, C.Q. Lin, C.L. Xiao, G.D. Gamble, G.J. Cooper, and I.R. Reid. 1999. Comparison of the effects of calcitonin gene-related peptide and amylin on osteoblasts. J. Bone Miner. Res. 14:1302-1309.
7. Cornish, J., K.E. Callon, U. Bava, S.A. Kamona, G.J. Cooper, and I.R. Reid. 2001. Effects of calcitonin, amylin, and calcitonin gene-related peptide on osteoclast development. Bone. 29:162-168.
8. Gebre-Medhin, S., H. Mulder, M. Pekny, G. Westermark, J. Tornell, P. Westermark, F. Sundler, B. Ahren, and C. Betsholtz. 1998. Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin). Biochem. Biophys. Res. Commun. 250:271-277.
9. Hoff, A.O., P. Catala-Lehnen, P.M. Thomas, M. Priemel, J.M. Rueger, I. Nasonkin, A. Bradley, M.R. Hughes, N. Ordonez, G.J. Cote, et al. 2002. Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene. J. Clin. Invest. 110:1849-1857.
10. Kahn, S.E., D.A. D'Alessio, M.W. Schwartz, W.Y. Fujimoto, J.W. Ensinck, G.J. Taborsky, Jr., and D. Porte, Jr. 1990. Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells. Diabetes. 39:634-638.
11. Katafuchi, T., K. Kikumoto, K. Hamano, K. Kangawa, H. Matsuo, and N. Minamino. 2003. Calcitonin receptor-stimulating peptide, a new member of the calcitonin gene-related peptide family. Its isolation from porcine brain, structure, tissue distribution, and biological activity. J. Biol. Chem. 278:12046-12054.
12. Lee, S.K., S.R. Goldring, and J.A. Lorenzo. 1995. Expression of the calcitonin receptor in bone marrow cell cultures and in bone: a specific marker of the differentiated osteoclast that is regulated by calcitonin. Endocrinology. 136:4572-4581.
13. Levin, M.E., V.C. Boisseau, and L.V. Avioli. 1976. Effects of diabetes mellitus on bone mass in juvenile and adult-onset diabetes. N. Engl. J. Med. 294:241-245.
14. Nicholson, G.C., J.M. Moseley, P.M. Sexton, F.A. Mendelsohn, and T.J. Martin. 1986. Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization. J. Clin. Invest. 78:355-360.
15. Parfitt, A.M., M.K. Drezner, F.H. Glorieux, J.A. Kanis, H. Malluche, P.J. Meunier, S.M. Ott, and R.R. Recker. 1987. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 2:595-610.
16. Quinn, J.M., M. Morfis, M.H. Lam, J. Elliott, V. Kartsogiannis, E.D. Williams, M.T. Gillespie, T.J. Martin, and P.M. Sexton. 1999. Calcitonin receptor antibodies in the identification ofosteoclasts. Bone. 25:1-8.
17. Robinson, F.L., A.W. Whitehurst, M. Raman, and M.H. Cobb. 2002. Identification of novel point mutations in ERK2 that selectively disrupt binding to MEK1. J. Biol. Chem. 277:14844-14852.
18. Roh, J., C.L. Chang, A. Bhalla, C. Klein, and S.Y. Hsu. 2003. Intermedin is a calcitonin/CGRP family peptide acting through the CRLR/RAMP receptor complexes. J. Biol. Chem. 10.1074/jbc.M305332200.
19. Su, Y., M. Chakraborty, M.H. Nathanson, and R. Baron. 1992. Differential effects of the 3′,5′-cyclic adenosine monophosphate and protein kinase C pathways on the response of isolated rat osteoclasts to calcitonin. Endocrinology. 131:1497-1502.
20. Suda, T., E. Jimi, I. Nakamura, and N. Takahashi. 1997. Role of 1 alpha,25-dihydroxyvitamin D3 in osteoclast differentiation and function. Methods Enzymol. 282:223-235.
21. Teitelbaum, S.L., and F.P. Ross. 2003. Genetic regulation of osteoclast development and function. Nat. Rev. Genet. 4:638-649.
22. Westermark, P., C. Wernstedt, T.D. O'Brien, D.W. Hayden, and K.H. Johnson. 1987. Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone. Am. J. Pathol. 127:414-417.
23. Wimalawansa, S.J. 1997. Amylin, calcitonin gene-related peptide, calcitonin, and adrenomedullin: a peptide superfamily. Crit Rev. Neurobiol. 11:167-239.
24. Zaidi, M., M. Pazianas, V.S. Shankar, B.E. Bax, C.M. Bax, P.J. Bevis, C. Stevens, C.L. Huang, D.R. Blake, B.S. Moonga, et al. 1993. Osteoclast function and its control. Exp. Physiol. 78:721-739.